Download PDF
Am J Perinatol 2019; 36(11): 1179-1187
DOI: 10.1055/s-0038-1676491
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Obestatin Reduces Intestinal Damage in Experimental Necrotizing Enterocolitis in Newborn Rats

Sabriye Korkut
1   Department of Neonatology, Faculty of Medicine, Erciyes University, Kayseri, Turkey
,
Ahmet Özdemir
1   Department of Neonatology, Faculty of Medicine, Erciyes University, Kayseri, Turkey
,
Arzu Hanım Yay
2   Department of Histology and Embryology, Faculty of Medicine, Erciyes University, Kayseri, Turkey
,
Betül Yalçın
2   Department of Histology and Embryology, Faculty of Medicine, Erciyes University, Kayseri, Turkey
,
Mahir Ceylan
1   Department of Neonatology, Faculty of Medicine, Erciyes University, Kayseri, Turkey
,
Levent Korkmaz
1   Department of Neonatology, Faculty of Medicine, Erciyes University, Kayseri, Turkey
,
Cevat Yazıcı
3   Department of Biochemistry, Faculty of Medicine, Erciyes University, Kayseri, Turkey
,
İnayet Güntürk
3   Department of Biochemistry, Faculty of Medicine, Erciyes University, Kayseri, Turkey
,
Selim Kurtoğlu
1   Department of Neonatology, Faculty of Medicine, Erciyes University, Kayseri, Turkey
› Author Affiliations Funding This work was supported by the Scientific Research Projects Unit of Erciyes University (Grant number: TSA-2015–5676).
Further Information

Publication History

14 August 2018

30 October 2018

Publication Date:
19 December 2018 (online)

    Permissions and Reprints

Abstract

Objective To investigate the effect of pretreatment with obestatin (OB), an endogenous hormone also found in mother's milk, in experimental necrotizing enterocolitis (NEC).

Study Design Pups were randomized into four groups: control, OB-control, NEC, and OB-NEC. NEC was induced by asphyxia and hypothermia in the NEC and OB-NEC groups. OB was administered to the OB-control and OB-NEC groups. Macroscopic scoring of the intestinal tract was evaluated and tissue samples were obtained for histopathological and biochemical examination on the fourth day.

Results OB improved the macroscopic appearance of the gut and the clinical score during the experiment (p  <  0.05). The rate of occurrence of NEC in the OB-NEC group was lower than the NEC group (p  =  0.001). OB prevented necrosis and reduced the number of apoptotic cells in the OB-NEC group compared with the NEC group (p  =  0.006). Furthermore, interleukin-6 and malondialdehyde levels in the OB-NEC group were lower than the NEC group (p  <  0.05).

Conclusion OB reduced intestinal damage and prevented necrosis through anti-inflammatory and antiapoptotic effects in experimental NEC. This effect of OB should be confirmed in clinical studies. Furthermore, future research should investigate whether OB plays a role in NEC pathogenesis or NEC is associated with OB levels in the serum and in breast milk.

Keywords

necrotizing enterocolitis - obestatin - treatment - rat - newborn
 

  • References

  • 1 Huda S, Chaudhery S, İbrahim H, Pramanik A. Neonatal necrotizing enterocolitis: clinical challenges, pathophysiology and management. Pathophysiology 2014; 21 (01) 3-12
    CrossrefPubMedGoogle Scholar
  • 2 Kandasamy J, Huda S, Ambalavanan N, Jilling T. Inflammatory signals that regulate intestinal epithelial renewal, differentiation, migration and cell death: Implications for necrotizing enterocolitis. Pathophysiology 2014; 21 (01) 67-80
    CrossrefPubMedGoogle Scholar
  • 3 Chen AC, Chung MY, Chang JH, Lin HC. Pathogenesis implication for necrotizing enterocolitis prevention in preterm very-low-birth-weight infants. J Pediatr Gastroenterol Nutr 2014; 58 (01) 7-11
    CrossrefPubMedGoogle Scholar
  • 4 Nanthakumar NN, Fusunyan RD, Sanderson I, Walker WA. Inflammation in the developing human intestine: A possible pathophysiologic contribution to necrotizing enterocolitis. Proc Natl Acad Sci U S A 2000; 97 (11) 6043-6048
    CrossrefPubMedGoogle Scholar
  • 5 Ren AJ, Guo ZF, Wang YK, Lin L, Zheng X, Yuan WJ. Obestatin, obesity and diabetes. Peptides 2009; 30 (02) 439-444
    CrossrefPubMedGoogle Scholar
  • 6 Çatlı G, Olgaç Dündar N, Dündar BN. Adipokines in breast milk: an update. J Clin Res Pediatr Endocrinol 2014; 6 (04) 192-201
    CrossrefPubMedGoogle Scholar
  • 7 Samson WK, White MM, Price C, Ferguson AV. Obestatin act in brain to inhibit thirst. Am J Physiol Regul Integr Comp Physiol 2007; 292 (01) 637-643
    CrossrefPubMedGoogle Scholar
  • 8 Carlini VP, Schiöth HB, Debarioglio SR. Obestatin improves memory performance and causes anxiolytic effects in rats. Biochem Biophys Res Commun 2007; 352 (04) 907-912
    CrossrefPubMedGoogle Scholar
  • 9 Szentirmai E, Krueger JM. Obestatin alters sleep in rats. Neurosci Lett 2006; 404 (1-2) 222-226
    CrossrefPubMedGoogle Scholar
  • 10 Camiña JP, Campos JF, Caminos JE, Dieguez C, Casanueva FF. Obestatin-mediated proliferation of human retinal pigment epithelial cells: regulatory mechanisms. J Cell Physiol 2007; 211 (01) 1-9
    CrossrefPubMedGoogle Scholar
  • 11 Pazos Y, Alvarez CJ, Camiña JP, Casanueva FF. Stimulation of extracellular signal-regulated kinases and proliferation in the human gastric cancer cells KATO-III by obestatin. Growth Factors 2007; 25 (06) 373-381
    CrossrefPubMedGoogle Scholar
  • 12 Granata R, Settanni F, Gallo D. , et al. Obestatin promotes survival of pancreatic beta-cells and human islets and induces expression of genes involved in the regulation of beta-cell mass and function. Diabetes 2008; 57 (04) 967-979
    CrossrefPubMedGoogle Scholar
  • 13 Ren AJ, Guo ZF, Wang YK. , et al. Inhibitory effect of obestatin on glucose-induced insulin secretion in rats. Biochem Biophys Res Commun 2008; 369 (03) 969-972
    CrossrefPubMedGoogle Scholar
  • 14 Dembiński A, Warzecha Z, Ceranowicz P. , et al. Administration of obestatin accelerates the healing of chronic gastric ulcers in rats. Med Sci Monit 2011; 17 (08) BR196-BR200
    PubMedGoogle Scholar
  • 15 Pamukçu O, Kumral ZN, Ercan F, Yegen BC, Ertem D. Anti-inflammatory effect of obestatin and ghrelin in dextran sulfate sodium-induced colitis in rats. J Pediatr Gastroenterol Nutr 2013; 57 (02) 211-218
    CrossrefPubMedGoogle Scholar
  • 16 Erşahin M, Ozsavcı D, Şener A. , et al. Obestatin alleviates subarachnoid haemorrhage-induced oxidative injury in rats via its anti-apoptotic and antioxidant effects. Brain Inj 2013; 27 (10) 1181-1189
    CrossrefPubMedGoogle Scholar
  • 17 Koç M, Kumral ZN, Özkan N. , et al. Obestatin improves ischemia/reperfusion-induced renal injury in rats via its antioxidant and anti-apoptotic effects: role of the nitric oxide. Peptides 2014; 60: 23-31
    CrossrefPubMedGoogle Scholar
  • 18 Boutsikou T, Briana DD, Boutsikou M. , et al. Cord blood chemerin and obestatin levels in large for gestational age infants. J Matern Fetal Neonatal Med 2013; 26 (02) 123-126
    CrossrefPubMedGoogle Scholar
  • 19 Zhang S, Zhai G, Zhang J, Zhou J, Chen C. Ghrelin and obestatin plasma levels and ghrelin/obestatin prepropeptide gene polymorphisms in small for gestational age infants. J Int Med Res 2014; 42 (06) 1232-1242
    PubMedGoogle Scholar
  • 20 Caplan MS, Lickerman M, Adler L, Dietsch GN, Yu A. The role of recombinant platelet-activating factor acetylhydrolase in a neonatal rat model of necrotizing enterocolitis. Pediatr Res 1997; 42 (06) 779-783
    CrossrefPubMedGoogle Scholar
  • 21 Yazıcı S, Akşit H, Korkut O, Sunay B, Çelik T. Effects of boric acid and 2-aminoethoxydiphenyl borate on necrotizing enterocolitis. J Pediatr Gastroenterol Nutr 2014; 58 (01) 61-67
    CrossrefPubMedGoogle Scholar
  • 22 Giannone PJ, Alcamo AA, Schanbacher BL, Nankervis CA, Besner GE, Bauer JA. Poly(ADP-ribose) polymerase-1: a novel therapeutic target in necrotizing enterocolitis. Pediatr Res 2011; 70 (01) 67-71
    PubMedGoogle Scholar
  • 23 Zani A, Cordischi L, Cananzi M. , et al. Assessment of a neonatal rat model of necrotizing enterocolitis. Eur J Pediatr Surg 2008; 18 (06) 423-426
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Dvorak B, Halpern MD, Holubec H. , et al. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol Gastrointest Liver Physiol 2002; 282 (01) G156-G164
    CrossrefPubMedGoogle Scholar
  • 25 Ceranowicz P, Warzecha Z, Dembinski A. Peptidyl hormones of endocrine cells origin in the gut--their discovery and physiological relevance. J Physiol Pharmacol 2015; 66 (01) 11-27
    PubMedGoogle Scholar
  • 26 Gao XY, Kuang HY, Liu XM, Ma ZB, Nie HJ, Guo H. Plasma obestatin levels in men with chronic atrophic gastritis. Peptides 2008; 29 (10) 1749-1754
    CrossrefPubMedGoogle Scholar
  • 27 Alexandridis E, Zisimopoulos A, Liratzopoulos N, Katsos I, Manolas K, Kouklakis G. Obestatin/ghrelin ratio: a new activity index in inflammatory bowel diseases. Inflamm Bowel Dis 2009; 15 (10) 1557-1561
    CrossrefPubMedGoogle Scholar
  • 28 Matuszyk A, Ceranowicz P, Warzecha Z. , et al. Obestatin accelerates the healing of acetic acid-induced colitis in rats. Oxid Med Cell Longev 2016; 2016: 2834386
    PubMedGoogle Scholar
  • 29 Morecroft JA, Spitz L, Hamilton PA, Holmes SJ. Plasma cytokine levels in necrotizing enterocolitis. Acta Paediatr Suppl 1994; 396: 18-20
    PubMedGoogle Scholar
  • 30 Harris MC, Costarino Jr AT, Sullivan JS. , et al. Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis. J Pediatr 1994; 124 (01) 105-111
    CrossrefPubMedGoogle Scholar
  • 31 Paul G, Khare V, Gasche C. Inflamed gut mucosa: downstream of interleukin-10. Eur J Clin Invest 2012; 42 (01) 95-109
    CrossrefPubMedGoogle Scholar
  • 32 Edelson MB, Bagwell CE, Rozycki HJ. Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 1999; 103 (4 Pt 1): 766-771
    CrossrefPubMedGoogle Scholar
  • 33 Aydemir C, Dilli D, Uras N. , et al. Total oxidant status and oxidative stress are increased in infants with necrotizing enterocolitis. J Pediatr Surg 2011; 46 (11) 2096-2100
    CrossrefPubMedGoogle Scholar
  • 34 Yurttutan S, Ozdemir R, Canpolat FE. , et al. Beneficial effects of Etanercept on experimental necrotizing enterocolitis. Pediatr Surg Int 2014; 30 (01) 71-77
    CrossrefPubMedGoogle Scholar
  • 35 Chan KL, Hui CW, Chan KW. , et al. Revisiting ischemia and reperfusion injury as a possible cause of necrotizing enterocolitis: role of nitric oxide and superoxide dismutase. J Pediatr Surg 2002; 37 (06) 828-834
    CrossrefPubMedGoogle Scholar
  • 36 Deshmukh DR, Mirochnitchenko O, Ghole VS. , et al. Intestinal ischemia and reperfusion injury in transgenic mice overexpressing copper-zinc superoxide dismutase. Am J Physiol 1997; 273 (4 Pt 1): C1130-C1135
    PubMedGoogle Scholar
  • 37 Miller MJ, McNeill H, Mullane KM, Caravella SJ, Clark DA. SOD prevents damage and attenuates eicosanoid release in a rabbit model of necrotizing enterocolitis. Am J Physiol 1988; 255 (5 Pt 1) G556-G565
    PubMedGoogle Scholar
  • 38 Clark JA, Lane RH, Maclennan NK. , et al. Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2005; 288 (04) G755-G762
    CrossrefPubMedGoogle Scholar
  • 39 Ford H, Watkins S, Reblock K, Rowe M. The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis. J Pediatr Surg 1997; 32 (02) 275-282
    CrossrefPubMedGoogle Scholar
  • 40 Jilling T, Lu J, Jackson M, Caplan MS. Intestinal epithelial apoptosis initiates gross bowel necrosis in an experimental rat model of neonatal necrotizing enterocolitis. Pediatr Res 2004; 55 (04) 622-629
    CrossrefPubMedGoogle Scholar
  • 41 Zuckerbraun BS, Otterbein LE, Boyle P. , et al. Carbon monoxide protects against the development of experimental necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 2005; 289 (03) G607-G613
    CrossrefPubMedGoogle Scholar
  • 42 Ozen S, Akisu M, Baka M. , et al. Insulin-like growth factor attenuates apoptosis and mucosal damage in hypoxia/reoxygenation-induced intestinal injury. Biol Neonate 2005; 87 (02) 91-96
    CrossrefPubMedGoogle Scholar
  • 43 Alloatti G, Arnoletti E, Bassino E. , et al. Obestatin affords cardioprotection to the ischemic-reperfused isolated rat heart and inhibits apoptosis in cultures of similarly stressed cardiomyocytes. Am J Physiol Heart Circ Physiol 2010; 299 (02) H470-H481
    CrossrefPubMedGoogle Scholar